NRXP (NRx Pharmaceuticals, Inc) Dana dhuwit perusahaan

nrxpharma.com - logo grafis emiten NRXP

NRx Pharmaceuticals (NRXP) develops drugs to combat severe depression, leveraging the long life cycle of its formulas. Analyzing the volume of physical cash on GURU.Markets, we note that 0.02 shows the current value of the metric. However, stringent FDA requirements for the therapy of suicidal states and pressure from global pharma behemoths create serious risks for business sustainability.

NRXP - Sisa dhuwit perusahaan NRx Pharmaceuticals Inc. ing rentang 04.07.2022 - 21.11.2026

Rincian metrik keuangan lan pasar NRx Pharmaceuticals Inc. (NRXP)

- indikator valuasi pasar bisnis:
Analisis fundamental perusahaan:NRx Pharmaceuticals, Inc
Produk mawa merek NRx Pharmaceuticals, Inc.

The cash dynamics of NRx Pharmaceuticals (NRXP) reflect management's current ability to sustain operational activities during the restructuring period and while awaiting program approvals. This indicator measures the total volume of liquid assets, serving as a guarantee of solvency and protection against default, although excessive accumulation without profitable investments may indicate inefficient capital management and a decline in return on assets.